Patent · US Active

Conjugates for the prevention or treatment of nicotine addiction

US8980276B2 · kind B2 · utility

3Cited by
6References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 2, 2011
Grant dateMar 17, 2015
Priority date
Expiry dateJun 9, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates in part to nicotine-derived hapten-carrier conjugates of the formula (III):wherein m, n, W, -(spacer)-, X* and Y are as defined in the description. In certain embodiments, said nicotine-derived hapten-carrier conjugates can be used to prepare vaccines for the treatment and/or prevention of nicotine addiction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.